| |
| |
|
| Insider
Information: |
Lewis Joel |
| Relationship: |
|
| City: |
Norcross |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
897,012 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$2,547,514 |
|
|
|
Indirect Value
|
$5,680 |
|
|
| Total
Shares |
899,012 |
|
|
| Total
Value |
$2,553,194 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 16.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-16 |
4 |
B |
$1.52 |
$1,520 |
I/I |
1,000 |
1,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-04-05 |
4 |
B |
$4.82 |
$3,214 |
D/D |
667 |
65,800 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2024-04-24 |
4 |
B |
$3.39 |
$3,390 |
I/I |
1,000 |
2,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-07 |
4 |
B |
$4.48 |
$4,484 |
D/D |
1,000 |
65,133 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-01-29 |
4 |
B |
$4.81 |
$4,805 |
D/D |
1,000 |
64,133 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-25 |
4 |
B |
$7.06 |
$7,058 |
D/D |
1,000 |
51,480 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-09-15 |
4 |
A |
$2.93 |
$15,151 |
D/D |
5,171 |
112,275 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-09-30 |
4 |
A |
$2.67 |
$16,666 |
D/D |
6,242 |
118,517 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-10-15 |
4 |
A |
$2.87 |
$16,666 |
D/D |
5,807 |
124,324 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-11-30 |
4 |
A |
$2.60 |
$16,666 |
D/D |
6,410 |
143,357 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-12-31 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
157,411 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-01-15 |
4 |
A |
$2.19 |
$16,666 |
D/D |
7,610 |
165,021 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-01-29 |
4 |
A |
$1.96 |
$16,666 |
D/D |
8,503 |
173,524 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-02-15 |
4 |
A |
$2.49 |
$16,666 |
D/D |
6,693 |
180,217 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-02-26 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
187,657 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-03-31 |
4 |
A |
$2.17 |
$16,666 |
D/D |
7,680 |
202,004 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-05-14 |
4 |
A |
$4.23 |
$16,666 |
D/D |
3,940 |
217,189 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-06-01 |
4 |
A |
$3.97 |
$16,666 |
D/D |
4,198 |
221,387 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-06-30 |
4 |
A |
$3.20 |
$16,666 |
D/D |
5,208 |
231,357 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-09-15 |
4 |
A |
$3.73 |
$16,666 |
D/D |
4,468 |
257,493 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-12-15 |
4 |
A |
$2.25 |
$16,666 |
D/D |
7,407 |
291,565 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-10-30 |
4 |
A |
$2.54 |
$16,667 |
D/D |
6,562 |
130,886 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2020-12-15 |
4 |
A |
$2.52 |
$16,667 |
D/D |
6,614 |
149,971 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-04-15 |
4 |
A |
$2.23 |
$16,667 |
D/D |
7,474 |
209,478 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-07-15 |
4 |
A |
$2.59 |
$16,667 |
D/D |
6,435 |
237,792 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
